Andrzej Jakubowiak to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Andrzej Jakubowiak has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.142
-
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Leukemia. 2013 Dec; 27(12):2351-6.
Score: 0.107
-
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2017 09; 17(9):555-562.
Score: 0.036